Tuvalu Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tuvalu Health Digest.

Press releases published on July 28, 2026

Jul. 28, 2026

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 28, 2026

YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada

Indeterminate GlobeNewswire

Jul. 28, 2026

Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK

Indeterminate GlobeNewswire

Jul. 28, 2026

Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences

Indeterminate GlobeNewswire

Jul. 28, 2026

Enlivex Announces $400,000,000 Private Placement

Indeterminate GlobeNewswire

Jul. 28, 2026

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

Indeterminate GlobeNewswire

Jul. 28, 2026

Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial

Indeterminate GlobeNewswire

Jul. 28, 2026

Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution

Indeterminate GlobeNewswire

Jul. 28, 2026

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth

Indeterminate GlobeNewswire

Jul. 28, 2026

Trevi Therapeutics to Participate in Upcoming August Conferences

Indeterminate GlobeNewswire

Jul. 28, 2026

Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET

Indeterminate GlobeNewswire

Jul. 28, 2026

Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference

Indeterminate GlobeNewswire

Jul. 28, 2026

Palvella Therapeutics to Host Second Quarter 2026 Financial Results and Corporate Update Conference Call on August 4, 2026

Indeterminate GlobeNewswire

Jul. 28, 2026

Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)

Indeterminate GlobeNewswire

Jul. 28, 2026

Venus Concept Obtains Exclusive Distribution Rights for the HIRONIC Doublo 2.0 Device in US and Canada

Indeterminate GlobeNewswire

Jul. 28, 2026

Kazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer

Indeterminate GlobeNewswire

Jul. 28, 2026

Lifecore Biomedical Signs Three New Customer Agreements

Indeterminate GlobeNewswire

Jul. 28, 2026

Antag Therapeutics Announces Dosing of First Patient in Phase 2a Trial of First-in-Class GIPR Antagonist AT7687

Indeterminate GlobeNewswire

Jul. 28, 2026

NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026

Indeterminate GlobeNewswire

Jul. 28, 2026

Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration

Indeterminate GlobeNewswire